
/
of the weight lost on semaglutide came back within a year of stopping.
That was the finding of the STEP 1 trial extension, where people stopped the medication after 68 weeks. Average weight loss fell from 17.3% to 5.6%. Coming off deserves a plan, not a drop.
1 in 7 Employers in one survey have dropped GLP-1 weight-loss coverage or plan to by 2027.
Plan your taper before January, not after it.
Your plan is ready: a step-by-step taper, led by Dr. Kara.








